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Background
Lynch Syndrome (LS) correlated colorectal carcinoma
(CRC) patients show a tendency towards the develop-
ment of multiple and metachronous lesions and, for this
reason, a surgical prophylactic treatment, as total colect-
omy, is warranted. Considering the quality of life of
patients treated with total colectomy, it is essential to
determine risk factors of metachronous CRC. Aim of
the study was to evaluate through a predictive model
the patients that could really benefit from a surgical
prevention.
Methods
We considered LS or suspected LS CRC patients
enrolled by our Institutional Register of Hereditary Col-
orectal Tumors and submitted to a surgical resection of
CRC, excluding those who had a total colectomy.
Patients were characterized according to their genotype
(MLH I, MSH2 and MSH6), sex and clinical features
(age at diagnosis, tumour site, stage, grading, presence
of colorectal adenomas and of extracolonic cancers) and
were stratified in 4 mutually exclusive groups according
to family characteristics: A) MMR gene mutation posi-
tive; B) Amsterdam criteria (ACI-II) positive, but muta-
tion negative; C) AC-like and D) high risk. In order to
identify a model for predicting metachronous CRC
occurrence, for each patients’ group a stepwise uncondi-
tional logistic regression model was fitted. All the
regression equation included terms for gender, age in
continuous as blocked terms. The predictive accuracy
was assessed using the area under the receiver operating
characteristics curve (AUC).
Results
A total of 1,604 CRC patients (M/F=1.02, 16.5% <40 yrs
old) were considered (600 in group A, 117 B, 530 C and
357 D). During the follow-up, 181 developed metachro-
nous CRC (11 %) and 354 (22%) an extracolonic cancer.
The risks of metachronous CRC at 10 years were 21%,
16%, 16%, and 14% for group A, B, C and D, respectively.
The predictive variables in the final model comprised for
each group were: A) MLHI mutation, the presence of col-
orectal adenomas and then occurrence of extracolonic can-
cers, B) occurrence of extracolonic cancers, C) high tumor
grade and presence of colorectal adenomas. No significant
predictors were identified for group D. AUC values, as a
measure of discrimination of the various models, were
0.72, 0.78 and 0.76 for group A, B and C, respectively.
Conclusions
Metachronous CRC is a long-term moderate risk in LS
patients. This suggests to recommend a prophylactic
colectomy only to selected patients with well defined
characteristics.
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